Related Experiment Video
Updated: Jul 19, 2026
Mouse Models for Graft Arteriosclerosis
Published on: May 14, 2013
Humanized mouse models for organ-specific autoimmune diseases
Manuel A Friese1, Lise T Jensen, Nick Willcox
1MRC Human Immunology Unit and Department of Clinical Neurology, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DS, United Kingdom.
Abstract:
Murine models for human autoimmune diseases are an essential tool for studying pathogenesis and for identifying new therapeutic targets. Mice are not the natural disease host, and conventional models have proved to be poor predictors of efficacy and safety in recent trials aiming to translate drug and biologic treatments to humans. Evidently, further steps towards recapitulating human diseases are urgently needed, for example using transgenic predisposing human HLA allele(s) plus T-cell receptor(s) implicated in a representative patient's autoimmune disease. The latest development - humanizing most of the immune system by transplanting human hematopoietic stem cells into severely immunodeficient mice - should lead to even better modeling.
Insights
Developing better animal models for human autoimmune diseases is crucial. Advanced methods like humanizing mouse immune systems offer improved disease modeling for drug development.
Area of Science:
- Immunology
- Translational Medicine
- Autoimmune Disease Research
Background:
- Murine models are vital for studying autoimmune disease pathogenesis and therapeutic targets.
- Conventional models often fail to predict human treatment efficacy and safety.
- There is a critical need for improved preclinical models that better recapitulate human autoimmune conditions.
Purpose of the Study:
- To highlight the limitations of current murine models for human autoimmune diseases.
- To discuss advancements in creating more accurate preclinical models.
- To emphasize the importance of improved models for drug discovery and development.
Main Methods:
- Reviewing the utility and shortcomings of existing murine models.
- Exploring strategies such as incorporating human HLA alleles and T-cell receptors.
- Introducing the concept of 'humanized' mice via hematopoietic stem cell transplantation.
Main Results:
- Conventional murine models show poor predictive value for human trials.
- Transgenic approaches with human components offer enhanced disease relevance.
- Humanized mouse models demonstrate potential for superior recapitulation of human immune responses.
Conclusions:
- Improved murine models are essential for advancing autoimmune disease research.
- Humanized mice represent a significant step forward in preclinical modeling.
- Enhanced models are key to successful translation of therapies from bench to bedside.
